Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Seles Maximilian |

** = Publikationen gelistet in SCI/SSCI/Pubmed

2023

Originalarbeit (Zeitschrift)

** Beijert, IJ; Hentschel, AE; Bründl, J; Compérat, EM; Plass, K; Rodríguez, O; Subiela, Henríquez, JD; Hernández, V; de, la, Peña, E; Alemany, I; Turturica, D; Pisano, F; Soria, F; Čapoun, O; Bauerová, L; Pešl, M; Bruins, HM; Runneboom, W; Herdegen, S; Breyer, J; Brisuda, A; Calatrava, A; Rubio-Briones, J; Seles, M; Mannweiler, S; Bosschieter, J; Kusuma, VRM; Ashabere, D; Huebner, N; Cotte, J; Mertens, LS; Claps, F; Masson-Lecomte, A; Liedberg, F; Cohen, D; Lunelli, L; Cussenot, O; El, Sheikh, S; Volanis, D; Côté, JF; Rouprêt, M; Haitel, A; Shariat, SF; Mostafid, AH; Nieuwenhuijzen, JA; Zigeuner, R; Dominguez-Escrig, JL; Hacek, J; Zlotta, AR; Burger, M; Evert, M; Hulsbergen-van, de, Kaa, CA; van, der, Heijden, AG; Kiemeney, LALM; Soukup, V; Molinaro, L; Gontero, P; Llorente, C; Algaba, F; Palou, J; N'Dow, J; Ribal, MJ; van, der, Kwast, TH; Babjuk, M; Sylvester, RJ; van, Rhijn, BWG Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive Spectrum.
Eur Urol Oncol. 2023; Doi: 10.1016/j.euo.2023.01.004
PubMed FullText FullText_MUG

 

Korrektur

** Sylvester, RJ; Rodríguez, O; Hernández, V; Turturica, D; Bauerová, L; Max, Bruins, H; Bründl, J; van, der, Kwast, TH; Brisuda, A; Rubio-Briones, J; Seles, M; Hentschel, AE; Kusuma, VRM; Huebner, N; Cotte, J; Mertens, LS; Volanis, D; Cussenot, O; Subiela, Henríquez, JD; de, la, Peña, E; Pisano, F; Pešl, M; van, der, Heijden, AG; Herdegen, S; Zlotta, AR; Hacek, J; Calatrava, A; Mannweiler, S; Bosschieter, J; Ashabere, D; Haitel, A; Côté, JF; El, Sheikh, S; Lunelli, L; Algaba, F; Alemany, I; Soria, F; Runneboom, W; Breyer, J; Nieuwenhuijzen, JA; Llorente, C; Molinaro, L; Hulsbergen-van, de, Kaa, CA; Evert, M; Kiemeney, LALM; N'Dow, J; Plass, K; Čapoun, O; Soukup, V; Dominguez-Escrig, JL; Cohen, D; Palou, J; Gontero, P; Burger, M; Zigeuner, R; Mostafid, AH; Shariat, SF; Rouprêt, M; Compérat, EM; Babjuk, M; van, Rhijn, BWG Erratum to "European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel" [Eur. Urol. 79(4) (2021) 480-488].
Eur Urol. 2023; Doi: 10.1016/j.eururo.2023.02.007
PubMed FullText FullText_MUG

 

2022

Originalarbeit (Zeitschrift)

** Beijert, IJ; Hentschel, AE; Bründl, J; Compérat, EM; Plass, K; Rodríguez, O; Subiela, Henríquez, JD; Hernández, V; de, la, Peña, E; Alemany, I; Turturica, D; Pisano, F; Soria, F; Čapoun, O; Bauerová, L; Pešl, M; Maxim, Bruins, H; Runneboom, W; Herdegen, S; Breyer, J; Brisuda, A; Calatrava, A; Rubio-Briones, J; Seles, M; Mannweiler, S; Bosschieter, J; Kusuma, VRM; Ashabere, D; Huebner, N; Cotte, J; Mertens, LS; Masson-Lecomte, A; Liedberg, F; Cohen, D; Lunelli, L; Cussenot, O; El, Sheikh, S; Volanis, D; Côté, JF; Rouprêt, M; Haitel, A; Shariat, SF; Mostafid, AH; Nieuwenhuijzen, JA; Zigeuner, R; Dominguez-Escrig, JL; Hacek, J; Zlotta, AR; Burger, M; Evert, M; Hulsbergen-van, de, Kaa, CA; van, der, Heijden, AG; A, L, M, Kiemeney, L; Soukup, V; Molinaro, L; Gontero, P; Llorente, C; Algaba, F; Palou, J; N'Dow, J; Ribal, MJ; van, der, Kwast, TH; Babjuk, M; Sylvester, RJ; van, Rhijn, BWG T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non-muscle-invasive Bladder Cancer Spectrum.
Eur Urol Focus. 2022; 8(6):1627-1634 Doi: 10.1016/j.euf.2022.04.014
PubMed FullText FullText_MUG

 

** Fluhrer, H; Hutterer, GC; Golbeck, S; Stidl, M; Niedrist, T; Pichler, R; Mischinger, J; Seles, M; Mannweiler, S; Spiegelberg, J; Bauernhofer, T; Jost, PJ; Ahyai, S; Zigeuner, R; Pichler, M; Barth, DA Improved overall survival of metastatic renal cell carcinoma patients in the era of modern tyrosine kinase inhibitors and immune checkpoint inhibitors: results from a real-life, population-based Austrian study comprising three decades of follow-up.
Ther Adv Med Oncol. 2022; 14: 17588359221134065 Doi: 10.1177/17588359221134065 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

** Maisel, F; Smolle, MA; Mollnar, S; Riedl, JM; Barth, DA; Seles, M; Terbuch, A; Rossmann, CH; Eisner, F; Mannweiler, S; Hutterer, G; Zigeuner, R; Pummer, K; Smolle-Jüttner, FM; Lindenmann, J; Stotz, M; Gerger, A; Jost, PJ; Bauernhofer, T; Pichler, M; Posch, F Benefit of Metastasectomy in Renal Cell Carcinoma: A Propensity Score Analysis.
Clin Genitourin Cancer. 2022; 20(4):344-353 Doi: 10.1016/j.clgc.2022.03.010
Web of Science PubMed FullText FullText_MUG

 

** Mischinger, J; Schöllnast, H; Zurl, H; Geyer, M; Fischereder, K; Adelsmayr, G; Igrec, J; Fritz, G; Merdzo-Hörmann, M; Elstner, J; Schmid, J; Triebl, A; Trimmel, V; Reiter, C; Steiner, J; Rosenlechner, D; Seles, M; Pichler, GP; Pichler, M; Riedl, J; Schöpfer-Schwab, S; Strobl, J; Hutterer, GC; Zigeuner, R; Pummer, K; Augustin, H; Ahyai, S; Mannweiler, S; Fuchsjäger, M; Talakic, E Combining targeted and systematic prostate biopsy improves prostate cancer detection and correlation with the whole mount histopathology in biopsy naïve and previous negative biopsy patients.
Front Surg. 2022; 9: 1013389 Doi: 10.3389/fsurg.2022.1013389 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Zeitschrift)

** Ritz, N; Hochstatter, R; Mikalauskas, S; Talakic, E; Seles, M; Scholl, W; Trutnovsky, G; Laky, R; Tamussino, K; Fluhr, H; Wolfler, M Interdisciplinary Approach to deep infiltrating Intestinal Endometriosis: Surgical Techniques and their Outcome
GEBURTSH FRAUENHEILK. 2022; 82(6):S43-S44. Doi: 10.1055/s-0042-1750227 [Oral Communication]
Web of Science FullText FullText_MUG

 

2021

Originalarbeit (Zeitschrift)

** Barth, DA; Sareban, N; Lindner, AK; Daller, LAJ; Matzhold, EM; Hutterer, G; Smolle, M; Mischinger, J; Riedl, JM; Seles, M; Mannweiler, S; Bauernhofer, T; Pummer, K; Pichler, R; Zigeuner, R; Schlenke, P; Pichler, M Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-up.
Urol Oncol. 2021; 39(10):736.e9-736.e16 Doi: 10.1016/j.urolonc.2021.06.005 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Seles, M; Mischinger, J; Zigeuner, R Conservative Treatment of Upper Urinary Tract Urothelial Carcinoma: Con.
Eur Urol Open Sci. 2021; 32: 35-37. Doi: 10.1016/j.euros.2021.08.003 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Sylvester, RJ; Rodríguez, O; Hernández, V; Turturica, D; Bauerová, L; Bruins, HM; Bründl, J; van der Kwast, TH; Brisuda, A; Rubio-Briones, J; Seles, M; Hentschel, AE; Kusuma, VRM; Huebner, N; Cotte, J; Mertens, LS; Volanis, D; Cussenot, O; Subiela Henríquez, JD; de la Peña, E; Pisano, F; Pešl, M; van der Heijden, AG; Herdegen, S; Zlotta, AR; Hacek, J; Calatrava, A; Mannweiler, S; Bosschieter, J; Ashabere, D; Haitel, A; Côté, JF; El Sheikh, S; Lunelli, L; Algaba, F; Alemany, I; Soria, F; Runneboom, W; Breyer, J; Nieuwenhuijzen, JA; Llorente, C; Molinaro, L; Hulsbergen-van de Kaa, CA; Evert, M; Kiemeney, LALM; N'Dow, J; Plass, K; Čapoun, O; Soukup, V; Dominguez-Escrig, JL; Cohen, D; Palou, J; Gontero, P; Burger, M; Zigeuner, R; Mostafid, AH; Shariat, SF; Rouprêt, M; Compérat, EM; Babjuk, M; van Rhijn, BWG European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel.
Eur Urol. 2021; 79(4):480-488 Doi: 10.1016/j.eururo.2020.12.033
Web of Science PubMed FullText FullText_MUG

 

** Tulchiner, G; Staudacher, N; Fritz, J; Hackl, M; Pichler, M; Seles, M; Shariat, SF; D'Andrea, D; Gust, K; Albrecht, W; Grubmüller, K; Madersbacher, S; Graf, S; Lusuardi, L; Augustin, H; Berger, A; Loidl, W; Horninger, W; Pichler, R Seasonal Variations in the Diagnosis of Testicular Germ Cell Tumors: A National Cancer Registry Study in Austria.
Cancers (Basel). 2021; 13(21): Doi: 10.3390/cancers13215377 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** van Rhijn, BWG; Hentschel, AE; Bründl, J; Compérat, EM; Hernández, V; Čapoun, O; Bruins, HM; Cohen, D; Rouprêt, M; Shariat, SF; Mostafid, AH; Zigeuner, R; Dominguez-Escrig, JL; Burger, M; Soukup, V; Gontero, P; Palou, J; van der Kwast, TH; Babjuk, M; Sylvester, RJ; Multi-center EAU Non-Muscle-Invasive Bladder Cancer Guidelines Panel Study Consortium on the WHO1973 WHO 2004 2016 Classification Systems for Grade Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non-muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel Study.
Eur Urol Oncol. 2021; 4(2):182-191 Doi: 10.1016/j.euo.2020.12.002
Web of Science PubMed FullText FullText_MUG

 

2020

Originalarbeit (Zeitschrift)

** Hentschel, AE; van Rhijn, BWG; Bründl, J; Compérat, EM; Plass, K; Rodríguez, O; Henríquez, JDS; Hernández, V; de la Peña, E; Alemany, I; Turturica, D; Pisano, F; Soria, F; Čapoun, O; Bauerová, L; Pešl, M; Bruins, HM; Runneboom, W; Herdegen, S; Breyer, J; Brisuda, A; Scavarda-Lamberti, A; Calatrava, A; Rubio-Briones, J; Seles, M; Mannweiler, S; Bosschieter, J; Kusuma, VRM; Ashabere, D; Huebner, N; Cotte, J; Mertens, LS; Cohen, D; Lunelli, L; Cussenot, O; Sheikh, SE; Volanis, D; Coté, JF; Rouprêt, M; Haitel, A; Shariat, SF; Mostafid, AH; Nieuwenhuijzen, JA; Zigeuner, R; Dominguez-Escrig, JL; Hacek, J; Zlotta, AR; Burger, M; Evert, M; Hulsbergen-van de Kaa, CA; van der Heijden, AG; Kiemeney, LALM; Soukup, V; Molinaro, L; Gontero, P; Llorente, C; Algaba, F; Palou, J; N'Dow, J; Babjuk, M; van der Kwast, TH; Sylvester, RJ Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019?
Urol Oncol. 2020; 38(5):440-448 Doi: 10.1016/j.urolonc.2019.10.002 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Seles, M; Hutterer, GC; Foßelteder, J; Svoboda, M; Resel, M; Barth, DA; Pichler, R; Bauernhofer, T; Zigeuner, RE; Pummer, K; Slaby, O; Klec, C; Pichler, M Long Non-Coding RNA PANTR1 is Associated with Poor Prognosis and Influences Angiogenesis and Apoptosis in Clear-Cell Renal Cell Cancer.
Cancers (Basel). 2020; 12(5): 1200 Doi: 10.3390/cancers12051200 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Smith, CG; Moser, T; Mouliere, F; Field-Rayner, J; Eldridge, M; Riediger, AL; Chandrananda, D; Heider, K; Wan, JCM; Warren, AY; Morris, J; Hudecova, I; Cooper, WN; Mitchell, TJ; Gale, D; Ruiz-Valdepenas, A; Klatte, T; Ursprung, S; Sala, E; Riddick, ACP; Aho, TF; Armitage, JN; Perakis, S; Pichler, M; Seles, M; Wcislo, G; Welsh, SJ; Matakidou, A; Eisen, T; Massie, CE; Rosenfeld, N; Heitzer, E; Stewart, GD Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors.
Genome Med. 2020; 12(1): 23-23. Doi: 10.1186/s13073-020-00723-8 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Zeitschrift)

** Pfniss, I; Laky, R; Trapp, E; Seles, M; Bracic, T; Taumberger, N; Hochstatter, R; Tamussino, K Ureteral Stenosis in Patients with deeply infiltrating Endometriosis - A Complication that is often detected too late.
GEBURTSH FRAUENHEILK. 2020; 80(10):E273-E273. Doi: 10.1055/s-0040-1718348 [Oral Communication]
Web of Science FullText FullText_MUG

 

** Pfniss, I; Laky, R; Trapp, E; Seles, M; Bracic, T; Taumberger, N; Hochstatter, R; Tamussino, K Ureteral Stenosis in deep infiltrating Endometriosis - a Complication often detected too late.
GEBURTSH FRAUENHEILK. Kongressabstracts zur Jahrestagung 2020 der Österreichischen Gesellschaft für Gynäkologie und Geburtshilfe (OEGGG). 2020; 80(06):E7-E7.-Jahrestagung der Österreichischen Gesellschaft für Gynäkologie und Geburtshilfe (OEGGG); JUN 10-13, 2020; Graz, AUSTRIA. Doi: 10.1055/s-0040-1713207 [Oral Communication]
Web of Science FullText FullText_MUG

 

2019

Originalarbeit (Zeitschrift)

** Mischinger, J; Fröhlich, E; Mannweiler, S; Meindl, C; Absenger-Novak, M; Hutterer, GC; Seles, M; Augustin, H; Chromecki, TF; Jesche-Chromecki, J; Pummer, K; Zigeuner, R Prognostic value of B7-H1, B7-H3 and the stage, size, grade and necrosis (SSIGN) score in metastatic clear cell renal cell carcinoma.
Cent European J Urol. 2019; 72(1): 23-31. Doi: 10.5173/ceju.2018.1858 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Zeitschrift)

** Moser, T; Smith, CG; Seles, M; Wcislo, G; Eldridge, M; Perakis, S; Mouliere, F; Lazzeri, I; Heider, K; Warren, A; Rosenfeld, N; Stewart, GD; Heitzer, E Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors.
CANCER RES. 2019; 79(13):-AACR Annual Meeting on Bioinformatics, Convergence Science, and Systems Biology; MAR 29-APR 03, 2019; Atlanta, GA. Doi: 10.1158/1538-7445.AM2019-1367 [Poster]
Web of Science FullText FullText_MUG

 

** Terzic, J; Fillafer, F; Posch, F; Pichler, R; Seles, M; Niedersuss-Beke, D; Tinchon, C; Loidl, W; Pichler, M; Jahn, S; Stoger, H; Bauernhofer, T; Lymphopenia impairs response to 1st-line tyrosine kinase inhibitor therapy in patients with metastatic clear-cell renal cell carcinoma and modulates the relative efficacy of sunitinib and pazopanib
WIEN KLIN WOCHENSCHR. 2019; 131: S447-S447.-Frühjahrstagung der OeGHO; APR 11-13, 2019; Linz, AUSTRIA. [Poster]
Web of Science FullText

 

2018

Originalarbeit (Zeitschrift)

** Terbuch, A; Adiprasito, JB; Stiegelbauer, V; Seles, M; Klec, C; Pichler, GP; Resel, M; Posch, F; Lembeck, AL; Stöger, H; Szkandera, J; Pummer, K; Bauernhofer, T; Hutterer, GC; Gerger, A; Stotz, M; Pichler, M MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients.
Int J Mol Sci. 2018; 19(10): Doi: 10.3390/ijms19103130 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Konferenzband)

** Terzic, J; Fillafer, F; Posch, F; Pichler, R; Seles, M; Pichler, M; Jahn, S; Stöger, H; Bauernhofer, T Lymphopenia impairs response to 1st-line therapy with sunitinib and pazopanib in patients with metastatic clear-cell renal cell carcinoma.
Oncology Research and Treatment . 2018; 41(Suppl4):42-43.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie,; SEP 28- OCT 2, 2018; Vienna, AUSTRIA. (ISBN: 978-3-318-06425-4 ) [Oral Communication]
Web of Science FullText

 

2017

Originalarbeit (Zeitschrift)

** Dalpiaz, O; Luef, T; Seles, M; Stotz, M; Stojakovic, T; Pummer, K; Zigeuner, R; Hutterer, GC; Pichler, M Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil-lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinoma.
Br J Cancer. 2017; 116(1):85-90 Doi: 10.1038/bjc.2016.393 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Seles, M; Posch, F; Pichler, GP; Gary, T; Pummer, K; Zigeuner, R; Hutterer, GC; Pichler, M Blood Platelet Volume Represents a Novel Prognostic Factor in Patients with Nonmetastatic Renal Cell Carcinoma and Improves the Predictive Ability of Established Prognostic Scores.
J Urol. 2017; 198(6):1247-1252 Doi: 10.1016/j.juro.2017.07.036
Web of Science PubMed FullText FullText_MUG

 

Übersichtsarbeit

** Schanza, LM; Seles, M; Stotz, M; Fosselteder, J; Hutterer, GC; Pichler, M; Stiegelbauer, V MicroRNAs Associated with Von Hippel-Lindau Pathway in Renal Cell Carcinoma: A Comprehensive Review.
Int J Mol Sci. 2017; 18(11): Doi: 10.3390/ijms18112495 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2016

Originalarbeit (Zeitschrift)

** Seles, M; Gutschi, T; Mayrhofer, K; Fischereder, K; Ehrlich, G; Gallé, G; Gutschi, S; Pachernegg, O; Pummer, K; Augustin, H Sampling of the anterior apical region results in increased cancer detection and upgrading in transrectal repeat saturation biopsy of the prostate.
BJU Int. 2016; 117(4):592-597 Doi: 10.1111/bju.13108 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Übersichtsarbeit

** Seles, M; Hutterer, GC; Kiesslich, T; Pummer, K; Berindan-Neagoe, I; Perakis, S; Schwarzenbacher, D; Stotz, M; Gerger, A; Pichler, M Current Insights into Long Non-Coding RNAs in Renal Cell Carcinoma.
Int J Mol Sci. 2016; 17(4):573-573 Doi: 10.3390/ijms17040573 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2015

Übersichtsarbeit

** Augustin, H; Mayerhofer, K; Seles, M; Pummer, K Is There a Role for Active Surveillance in Low-Risk Prostate Cancer?
Urol Int. 2015; 95(2):125-131 Doi: 10.1159/000371895 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2014

Originalarbeit (Zeitschrift)

** Seles, M; Huemer, GM Utilization of bilateral infragluteal flaps for correction of overaggressive gluteal liposuction.
Ann Plast Surg. 2014; 72(3):270-273 Doi: 10.1097/SAP.0b013e318269e4ab (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

2013

Originalarbeit (Zeitschrift)

** Fischerauer, EE; Manninger, M; Seles, M; Janezic, G; Pichler, K; Ebner, B; Weinberg, AM BMP-6 and BMPR-1a are up-regulated in the growth plate of the fractured tibia.
J Orthop Res. 2013; 31(3):357-363 Doi: 10.1002/jor.22238 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2010

Abstract (Zeitschrift)

** Kutschera, J; Haim, M; Seles, M; Riccabona, M; Urlesberger, B; Muller, W Congenital frontonasal Tumor - Nasal Glioma?
KLIN PADIAT. 2010; 222: S106-S106. [Poster]
Web of Science

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum